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Abstract
Background: Prolonged pregnancies are associated with increased rate of maternal and fetal
complications. Post term women could be divided into at least two subgroups, one where
parturition is possible to induce by prostaglandins and one where it is not. Our aim was to study
parameters in cervical biopsies in women with spontaneous delivery at term (controls) and
compare to those that are successfully induced post term (responders), and those that are not
induced (non-responders), by local prostaglandin treatment.
Methods: Stromal parameters examined in this study were the accumulation of leukocytes (CD45,
CD68), mRNAs and/or proteins for the extracellular matrix degrading enzymes (matrix
metalloproteinase (MMP)-2, MMP-8 and MMP-9), their inhibitors (tissue inhibitor of MMP (TIMP)-
1 and TIMP-2), interleukin-8 (IL-8), the platelet activating factor-receptor (PAF-R), syndecan-1 and
estrogen binding receptors (estrogen receptor (ER)α, ERβ and G-coupled protein receptor (GPR)
30) as well as the proliferation marker Ki-67.
Results: The influx of leukocytes as assessed by CD45 was strongest in the responders, thereafter
in the controls and significantly lower in the non-responders. IL-8, PAF-R and MMP-9, all
predominantly expressed in leukocytes, showed significantly reduced immunostaining in the group
of non-responders, while ERα and GPR30 were more abundant in the non-responders, as
compared to the controls.
Conclusion: The impaired leukocyte influx, as reflected by the reduced number of CD45 positive
cells as well as decreased immunostaining of IL-8, PAF-R and MMP-9 in the non-responders, could
be one explanation of the failed ripening of the cervix in post term women. If the decreased
leukocyte influx is a primary explanation to absent ripening or secondary, as a result of other
factors, is yet to be established.
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Background
The human uterine cervix is an extracellular matrix (ECM)
organ. The cervical ripening at term is clinically recog-
nized as softening and dilation. This process corresponds
to a remodelling of the cervical ECM with a changed pro-
teoglycan composition and an increased collagen turno-
ver resulting in differently organized collagen fibrils [1,2].
This remodelling of the cervix is necessary for a normal
onset and progress of parturition.
The ripening process is characterized by inflammatory
events, such as extravasation of neutrophils and macro-
phages [3-5] and an increased cervical level of pro-inflam-
matory cytokines such as interleukin (IL)-8 [4,6]. Post-
term pregnancies, gestational length of >42 weeks, are
associated with increased rates of maternal and fetal com-
plications [7,8]. Among mothers delivering post term
there is a significant risk in subsequent post term births,
indicating that there are factors, genetic or other, that
influence pregnancy length [9]. It is common practice
worldwide to induce parturition when gestational age
increases beyond 41 weeks, since the risk of complications
is increasing after week 41 [10,11]. In Sweden there is a
consensus to induce labour after 42 weeks of gestation.
Most women respond to cervical prostaglandin applica-
tion and labour is induced, but there is a group of women
where no progress is achieved [12].
In previous studies we have shown that expression of
estrogen receptor (ER)α and ERβ are varying in cervix
biopsies obtained from women that are non pregnant,
term pregnant or immediately postpartum [3,13].
Recently several articles regarding a specific estrogen
receptor in the cell membrane, the G-protein coupled
receptor 30 (GPR30) have been published [14-16].
GPR30 has been described in endometrial and ovarian
cancer cells, but to our knowledge nothing is known from
in vivo expression in the human cervix.
Platelet-activating factor (PAF) is a lipid pro-inflamma-
tory mediator, involved in several reproductive processes,
i.e. parturition [17]. PAF is a phospholipid synthesized by
leukocytes, blood platelets and vascular endothelial cells
[18]. PAF-R is a G-protein coupled membrane receptor
with an estrogen responsive element within its promoter
region, enabling regulation by estrogens [19]. We have
found that immunostaining of PAF-R was higher in cervi-
cal stroma in term pregnant women than immediately
after delivery [20]. The activation of the PAF-R is associ-
ated with cytoskeletal remodelling and expression of pro-
inflammatory modulators, such as COX-2, IL-6 and IL-8
[21].
In a previous study we identified cervical stromal fibrob-
lasts and smooth muscle cells as main sources of matrix
metalloproteinase (MMP)-2, whereas the MMP-9 protein
was observed exclusively in invading leukocytes [22].
Both MMPs were shown to be increased in the end of
pregnancy as compared to cervical biopsies from non-
pregnant women [22]. These data indicate the involve-
ment of MMP-2 and MMP-9 in the cervical ripening proc-
ess. The MMP family consists of more than 20 members
with broad substrate specificities [23]. Main substrates for
collagenases (MMP-1, -8, and -13) are fibrillar and non-
fibrillar collagens. Primary targets of gelatinases (MMP-2
and -9) are denatured collagen IV, elastin, proteoglycans
and fibronectin [24]. Syndecan-1 (S-1) is a cell surface
proteoglycan that binds cells to the extracellular matrix
and acts as a regulator of chemokine function [25]. In rat
uterus, using microarray technology, we found that S-1
was clearly estrogen dependent [26]. Ki-67 is a marker for
proliferation, and estrogens are known to induce cellular
proliferation [27]. Thus, detection of S-1 and Ki-67 could
indicate level of estrogen stimulation.
The aim of this study was to determine the parameters
described above, in the cervix at term after spontaneous
vaginal delivery in comparison to that of women with
unripe cervices post term, both those responding to pros-
taglandin treatment and those who did not respond, to
find out possible differences.
Methods
All women were nulliparous healthy, non-smoking, had
uncomplicated pregnancies and were without medica-
tion. The gestational length was estimated according to
ultrasound dating in the second trimester of gestation.
The post term groups consisted of women with an unripe
cervix defined as a Bishop score ≤ 5 points. Prostaglandin-
E2 in viscous gel (Minprostin® Pharmacia, Sweden) was
administered locally to induce cervical priming. Oxytocin
infusion (Syntocinon® 10 U/glucose 5.5% 500 mL) for
augmentation of labour was administered to every
woman in the responder group 5 h after the latest prostag-
landin application, to a five out of ten women in the non-
responder group 5 h after the latest prostaglandin applica-
tion and to all woman in the control group during the
active phase of labour, if failure to progress after 2 h
according to the clinical guidelines [28].
The group that responded to Miniprostin treatment
(responders = R, n = 13), i.e. who underwent vaginal par-
turition after successful cervical priming and labour
induction (biopsy obtained immediately post partum)
had a mean age (± SD) of 29.4 years ± 5.8, a median ges-
tational length of 42+4 weeks (range 42+1 to 42+6), and
a median Bishop score of 3 points (range 0–4) before
treatment. This group received a median of total prostag-
landin treatment of 1.0 mg (range 1.0–2.0).Reproductive Biology and Endocrinology 2008, 6:36 http://www.rbej.com/content/6/1/36
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The group of women who did not respond (non-respond-
ers = NR, n = 10) to Miniprostin priming, i.e. experienced
a failed induction (biopsy taken after caesarean section),
had a mean age of 30.6 years ± 1.9, a median gestational
length of 42+4 weeks (range 42+3 to 42+6) and a mean
Bishop score of 2 points (range 0–4) before treatment.
These women received a median of 4.0 (range 0.5–7.0)
mg of prostaglandin treatment.
As controls we collected biopsies immediately after deliv-
ery from women who had a spontaneous onset of labour
and underwent vaginal delivery at normal gestational
length (controls = C, n = 18). These women had a mean
age of 29.3 years ± 4.9 and a median gestational age of
40+1 weeks (range 37+0 to 41+1).
Cervical biopsies (150–300 mg) were taken transvaginally
at the 12 o'clock position at partus or immediately after
emergency caesareans, by one physician (YSV). The study
was approved by the Local Ethics Committee (Dnr 99–
099), and informed consent was obtained from all
women before biopsies were collected. The biopsies were
when possible divided into 2 pieces, one immediately fro-
zen and the other was immersion-fixed in 4 % formalde-
hyde at 4°C overnight, stored at 4°C in 70% ethanol and
thereafter embedded in paraffin. When the biopsy was too
small to be divided, only a fixed sample was prepared,
therefore RNA preparations are not available from all
samples.
IL-8 immunostaining was also performed in samples from
a previously published study, for details on the non-preg-
nant (NP), term pregnant (TP) and post partum (PP)
groups, see Wang et al. [13]. The PP group is similar to the
control group of the post term study, i.e. biopsies are
obtained immediately after spontaneous vaginal delivery
at term.
RNA preparation and reverse transcription
Total RNA from frozen cervical tissue samples was puri-
fied with the RNeasy® kit (Qiagen GmbH, Hilden, Ger-
many) according to a procedure recommended by
manufacturer for RNA isolation from fibrous tissues. Two
μg of total RNA from each sample was reverse transcribed
at 37°C for 60 min in a final volume of 30 μl with a reac-
tion mixture (Qiagen GmbH, Hilden, Germany) contain-
ing 1 × RT buffer, dNTP mix (0.5 mM each dNTP), 600 ng
random primers (Invitrogen, Paisley, UK), 10 units RNase
inhibitor (Superase-In, Ambion, Austin, TX), and 4 U of
Omniscript™ reverse transcriptase (Qiagen).
Real time PCR analysis
The oligonucleotide primers for ERα, ERβ, GPR30, MMP-
2, MMP-8, MMP-9, TIMP-1, TIMP-2, S-1, PAF-R and
Cyclophilin A are presented in Table 1, as well as their pre-
dicted sizes. Real time PCR was performed in a DNA
Engine Opticon™ 2 System (MJ Research, Waltham, MA).
For PCR, the cDNAs corresponding to 40–100 ng (see
Table 1) RNA were added to 10 μl of Quantitect™ SYBR®
Green PCR mix (Qiagen) containing HotStarTaq DNA
polymerase, PCR buffer, dNTP mixture and 0.3 μM of
each oligonucleotide primer in a final volume of 20 μl.
The reactions were performed in opaque white 0.2 ml
low-profile strip tubes sealed with optical flat caps (TLS-
0851, TCS-0803, MJ Research, Waltham, MA). After initial
incubation for 15 min at 95°C, the samples were sub-
jected to 40–44 cycles of 10s at 94°C, 15–20s at 55–58°C
(see Table 1) and 20s at 72°C with a final extension step
at 72°C for 5 min. All reactions were performed twice. The
purity of PCR products was confirmed by a melting curve
analysis in all experiments (data not shown). The oligo-
nucleotide primers are listed in Table 1. All primers were
designed to span an intron/exon boundary or to flank an
intron, thus, amplification of contaminating DNA was
eliminated. Each PCR assay included a negative control
containing a RNA sample without reverse transcription.
The primers were based on the sequences of the human
genes. The primer pairs (Table 1) were designed with
Primer3 software [29].
Quantification of mRNA
To standardize the quantification method, cyclophilin A
was selected out of several tested housekeeping genes as
an invariable internal control (p = 0.482). The PCR ampli-
fication rate and the cycle threshold (Ct) values were
related to a standard curve using Opticon Monitor 3.0
software (MJ Research, Waltham, MA). The values of rela-
tive expression of genes of interest were normalized
against the cyclophilin A product.
Immunohistochemical analysis
Immunostaining for the determination of ERα, ERβ,
GPR30, MMP-9, cd45, cd68, S-1, Ki-67, IL-8 and PAF-R
utilizing the avidin-biotin peroxidase complex (ABC) pro-
cedure was performed [30]. The 5 μm paraffin sections
prepared from cervical biopsies were first dewaxed in Bio-
clear (Bio-Optica, Milan, Italy), rehydrated and washed
with phosphate-buffered saline (PBS; pH 7.4)) (ERβ and
PAF-R in Tris-buffered saline (TBS)). Thereafter the sec-
tions were subjected to microwave antigen retrieval in
0.01 M sodium citrate buffer (pH 6.0) for 10 min and
then allowed to cool for 20 min. Subsequently, endog-
enous peroxidase activity was quenched by immersion in
3% hydrogen peroxide (Merck) in methanol for 10 min at
room temperature; followed by blocking non-specific
binding of the primary antibody by incubation as shown
in Table 2, at room temperature (RT). The sections were
then incubated with the primary antibodies (see Table 2).
For the negative controls the primary antibody was
replaced by mouse IgG (or in the case of GPR30 rabbitReproductive Biology and Endocrinology 2008, 6:36 http://www.rbej.com/content/6/1/36
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IgG) at a corresponding concentration to the antibody it
replaced.
The secondary biotinylated antibody (Table 3) was incu-
bated as shown in Table 3, followed by incubation with
an avidin-biotin horseradish peroxidase complex
(Vectastain Elite, Cat# PK-6100) for 30 min at RT. The site
of the bound enzyme was visualized by the application of
3,3'-diaminobenzidine (DAB kit, DAKO, CA), a chro-
mogen which produces a brown, insoluble precipitate
when incubated with enzyme. The sections were counter-
stained with haematoxylin and dehydrated before they
were mounted with Pertex (Histolab, Gothenburg).
To obtain negative controls for the immunohistochemis-
try assays, the mouse monoclonal antibodies were
replaced by a normal mouse IgG of the same concentra-
tion as the primary antibody. The polyclonal GPR30 anti-
body was replaced by normal goat IgG of equal
concentration.
Image analysis
A Leica microscope and Sony video camera (Park Ridge,
NJ, USA) connected to a computer with an image analysis
system (Leica Imaging System Ltd, Cambridge, UK) was
used to assess quantitative values from immunohisto-
chemistry. The quantification of immunostaining was
performed as described previously [30]. Thus, quantifica-
tion of immunostaining was performed on the digitized
images of systematic randomly selected fields of cervical
stroma, from which non-stromal elements (e.g. epithe-
lium and glands) were interactively removed. Ten to 12
fields of stromal cells were measured separately in each
tissue section. By using color discrimination software, the
total area of positively stained cells (brown reaction prod-
uct) was measured, and expressed as a ratio of the total
Table 1: Oligonucleotide primers used for real-time PCR, template amount and their annealing temperatures.
Gene Accession No. or Reference Primer
F = forward; R = reverse
Position cDNA Annealing step
MMP-2 BC002576 F: gtatttgatggcatcgctca bp 1695-1714 40 ng 56°C/20s
R: cattccctgcaaagaacaca bp 1891-1871
product bp 198
MMP-8 NM_002424 F: ctttcagggaaaccagcaac bp 790-809 80 ng 55°C/20s
R: gcttggtccagtaggttgga bp 893-874
product bp 104
MMP-9 BC006093 F: cgctaccacctcgaactttg bp 1124-1143 40 ng 56°C/20s
R: gccattcacgtcgtccttat bp 1319-1300
product bp 198
TIMP-1 NM_003254 F: tgacatccggttcgtctaca bp 299-318 40 ng 56°C/20s
R: tgcagttttccagcaatgag bp 400-381
product bp 102
TIMP-2 PMID
15231657
[50]
F: gagcctgaaccacaggtacca bp 728-748 40 ng 58°C/15s
R: tctgtgacccagtccatcca bp 841-822
product bp 114
PAF-R NM_000952 F: cagagacacacggtcactgc bp 44-63 40 ng 56°C/15s
R: catgtgggaggagtcatgtg bp 154-135
product bp 111
S-1 NM_002997 F: ggagcaggacttcacctttg bp 869-888 50 ng 59°C/30s
R: cccagcacctctttcctgt bp 1009-991
product bp 141
ERα NM_000125 F: cttgctcttggacaggaacc bp 1581-1600 80 ng 56°C/20s
R: tcctctccctgcagattcat bp 1691-1672
product bp 111
ERβ NM_001437 F: tgcggaacctcaaaagagtc bp 715-734 80 ng 56°C/20s
R: catccctctttgaacctgga bp 854-835
product bp 140
GPR30 NM_001505 F: agactgtgaaatccgcaacc bp 364-383 100 ng 57°C/15s
R: aagtgagcctggcatttgt bp 663-644
product bp 300
Cyclophilin A XM_004890 F: gtggtgtttggcaaagtgaa bp 401-420 40 ng 56°C/20s
R: tcgagttgtccacagtcagc bp 516-497
product bp 116Reproductive Biology and Endocrinology 2008, 6:36 http://www.rbej.com/content/6/1/36
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area of cell nuclei (brown reaction product + blue haema-
toxylin).
Manual scoring
Two observers blinded to the identity of the slides (LS,
BM) performed all the assessments. The staining was eval-
uated semi-quantitatively using a grading system. The
staining intensity and amount of positive cells were
graded on a scale of (0) no staining, (1) faint/few positive
cells, (2) moderate/20–50% cells positive and (3) strong
staining/majority of cells positive.
Table 2: Antibodies used in the study.
Protein Order number and company Type Dilution Incub. time Blocking
CD45RB M0833 (B cells, T cells subsets, monocytes, macrophages and some granulocytes) DAKO 
A/S.
Mc mouse
anti-human
1:200 +4°C o/n D
CD68 M0876 (macrophages) DAKO A/S, Glostrup, Denmark Mc mouse
anti-human
1:200 +4°C o/n D
MMP-9 MS-817-P0, NeoMarkers Inc Mc mouse
anti-human
1:400 RT 60 min D
IL-8 sc-73321, Santa Cruz Biotechnology, Inc Mc mouse
anti-human
1:200 +4°C o/n A
PAF-R 160600, Cayman chemical, Mc mouse
anti-human
1:350 +4°C o/n E
S-1
(CD138)
M7228, DakoCytomation, Mc mouse
anti human
1:50 RT
30 min
A
ERα 2nd Gen 08-1149, Zymed Laboratories Inc Mc mouse
anti-human
1:5 +4°C o/n A
ERβ Serotec Ltd, MCA1974 Mc mouse
anti-human
1:20 +4°C o/n B
GPR30 LS-A4272, LifeSpan BioSciences Pc rabbit
anti-human
1:300 RT
60 min
C
Ki-67 NCL-Ki67-MM1, Novocastra Laboratories Ltd Mc mouse
anti human
1:200 +4°C o/n A
Mc = monoclonal; Pc = polyclonal, A = 1.5% normal horse serum (NHS) in PBS for 30 min, B = 1.5% normal horse serum (NHS) in TBS containing 
5% bovine serum albumin (BSA) for 45 min, C = 1.5% normal goat serum (NGS) in PBS containing 5% bovine serum albumin (BSA) for 30 min, D = 
1.5% normal horse serum (NHS) in PBS for 45 min, E = 1.5% normal horse serum (NHS) in TBS for 45 min.
NHS = normal horse serum (Vector Laboratories, Burlingame, CA).
NGS = normal goat serum (DakoCytomation, Glostrup, Denmark).
Table 3: Secondary anti-bodies used in the study, their dilution, buffers and incubation time.
Protein 2nd Ab Dilution Buffer Incubation
CD45RB biotinylated horse
anti-mouse
1:200 1.5% NHS in PBS 60 min RT
CD68 biotinylated horse
anti-mouse
1:200 1.5% NHS in PBS 60 min RT
MMP-9 biotinylated horse
anti-mouse
1:200 1.5% NHS in PBS 60 min RT
IL-8 biotinylated horse
anti-mouse
1:200 1.5% NHS in PBS 30 minRT
PAF-R biotinylated horse
anti-mouse
1:200 1.5% NHS in TBS 30 min RT
S-1
(CD138)
biotinylated horse
anti-mouse
1:200 1.5% NHS in PBS 30 min RT
ERα biotinylated horse
anti-mouse
1:200 1.5% NHS in PBS 30 minRT
ERβ biotinylated horse
anti-mouse
1:200 1.5% NHS in TBS + 5% BSA 60 min RT
GPR30 biotinylated goat
anti-rabbit
1:200 1.5% NGS in PBS + 5% BSA 30 min RT
Ki67 biotinylated horse
anti-mouse
1:200 1.5% NHS in PBS 30 min RT
biotinylated horse anti-mouse antibody (Vector, Cat# BA-2000).
biotinylated goat anti-rabbit antibody (Vector, Cat# BA-1000).Reproductive Biology and Endocrinology 2008, 6:36 http://www.rbej.com/content/6/1/36
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Statistical analysis
Statistical calculation was performed by a parametrical
method (one way ANOVA followed by Scheffés test to
evaluate significance) for patient age. For all other param-
eters statistical calculations were performed by the non-
parametric method ANOVA on ranks (Kruskal-Wallis test)
and significances were evaluated by Dunn's test. Values
are considered significantly different when P < 0.05.
Results
There was no difference between the study groups regard-
ing age, and no difference between the R and NR groups
in the Bishop score before treatment. The gestational age
of the control group (40+1) was significantly shorter than
that of the R and NR groups (42+4 in both). The NR group
received, as compared to the R group, significantly more
prostaglandin (4 to 1 mg in total) and had more times of
application (3 to 1.5 times) before delivery.
Due to the very small biopsies we could collect there were
just four samples available for the NR group in the PCR
assays, why the power of those calculations is less than the
0.80 that is desired. Therefore we are less likely to detect a
difference when one actually exists. We show the results
for the mRNA determinations, even if there are no signif-
icant differences, to enable for the viewer to judge and to
allow comparison with immunostaining results. In addi-
tion, the mRNA levels are determined in a RNA prepara-
tion from a homogenate of the cervical biopsy, why
potential differences between different cell types could
even out each other.
Leukocytes
Immunostaining of CD45 showed that there are less leu-
kocytes in the NR group than in the responders (Figure 1,
upper panel; Figure 2A–C), indicating that prostaglandin
treatment, when successful, induces leukocyte influx.
CD68 immunostaining (Figure 2M) showed no signifi-
cant difference between groups (Figure 1, middle panel).
MMPs and TIMPs
No significant differences in MMP-2 mRNA levels
between the study groups were found (p= 0.57). There
was a tendency to a decreased level of MMP-8 mRNA in
the NR group as compared to the C and R groups (p =
0.07) (Figure 3, upper panel). The MMP-9 mRNA level
was lower in the NR group as compared to the controls
(Figure 3, middle panel). Immunostaining with the MMP-
9 antibody showed that the leukocytes stained positive
and scoring was not performed (Figure 2D–F).
There were no significant differences in the mRNA levels
of TIMP-1 and TIMP-2 between groups (p = 0.103 and p =
0.677, respectively).
PAF-R
The PAF-R mRNA level was lower in the NR group as com-
pared with the controls (Figure 3, bottom panel). There is
also less cells positively stained for PAF-R in the NR group,
as compared to both the R and C groups (Figure 1, bottom
panel; Figure 2G–I), when scoring the stroma which to a
large extent contained positively stained leukocytes.
IL-8
Immunostaining of IL-8 showed that there are more leu-
kocytes staining positive in the cervix from women imme-
diately post partum (PP), than in term pregnancy (TP) or
non-pregnant (NP) (Figure 4A–C; Table 4). In addition,
the glandular epithelium also stained more positive in the
PP as compared to the NP group (Table 4). In the non-
responders of the present study, there were less IL-8
Immunostaining results of CD45, CD68 and PAF-R Figure 1
Immunostaining results of CD45, CD68 and PAF-R. 
CD45 (top), CD68 (middle) and PAF-R (bottom) immunos-
taining results in stroma, as assessed by image analysis (top) 
and manual scoring (middle, bottom) in cervical samples from 
controls (C) (n = 18), responders (R) (n = 13) and non-
responders (NR) (n = 9). The "box-and-whisker plot" repre-
sents the median value with 50% of all data falling within the 
box. The whiskers extend to the 5th and 95th percentiles. 
Boxes with different letter designations are significantly dif-
ferent, p < 0.05.
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Representative images of CD45, MMP-9, PAF-R, syndecan-1 and CD68 immunostaining Figure 2
Representative images of CD45, MMP-9, PAF-R, syndecan-1 and CD68 immunostaining. Representative images of 
the immunostaining results for CD45 (A-C), MMP-9 (D-F), PAF-R (G-I), Syndecan-1 (J-L) and CD68 (M). A negative control 
is shown for monoclonal antibodies (N) where the primary antibody (in this example CD45) was replaced by an equal amount 
of mouse IgG. Abbreviations: G: gland; V: vessel and SQ: squamous epithelium. The magnification bars represent 30 μm in all 
images but D-F, where it is 50 μm.Reproductive Biology and Endocrinology 2008, 6:36 http://www.rbej.com/content/6/1/36
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immunopositive leukocytes as compared to both the
responders (R) and the controls (Figure 4D–F; Table 4). A
negative control, where the primary antibody was
replaced by a equal amount of mouse IgG, is shown in
Figure 4G.
Syndecan-1
The syndecan-1 (S-1) mRNA level did not differ signifi-
cantly between the groups. Over all stromal S-1 immunos-
taining did not differ between the groups, but when we
scored stroma close to glands and stroma close to squa-
mous epithelium separately, there were significantly more
S-1 immunostaining in the stroma close to glands in the
C group (n = 7), as compared to the responders (n = 3) (p
= 0.042) (Figure 2J and 2K, respectively). There were not
glands present in all samples why the number of samples
analyzed is less for S-1, and only one sample from the NR
group had glands, why we could do no statistical compar-
ison to that group. The squamous epithelium was strongly
stained in all groups (Figure 2L). A representative image of
the negative control for the monoclonal antibodies is
shown in Figure 2N.
Estrogen receptors and Ki-67
ERα
There are no significant differences in the mRNA level
between the study groups (Figure 5, upper panel), but the
protein level in stroma was significantly lower in the con-
trol group as compared to the R and NR groups (Figures 6,
upper panel; Figure 7A–C).
ERβ
No significant differences in the mRNA level between
groups were found (Figure 5, middle panel). A tendency
to more immunostaining in the stroma was found in the
NR group as compared to controls (p = 0.073) (Figure 6,
middle panel; Figure 7D–F).
GPR30
The mRNA levels of GPR30 did not differ between groups
(Figure 5, bottom panel). Immunostaining of GPR30 in
cervical stroma was stronger in the NR group as compared
to controls (Figure 6, bottom panel; Figure 7G–I).
Ki-67
Immunostaining with the antibody directed towards the
proliferation marker Ki-67 showed no differences
between groups (data not shown). Typically the squa-
mous epithelium was positive while most stroma cells
were negative (Figure 7K).
A representative image of the negative controls for the
monoclonal antibodies is shown in Figure 7J, while a neg-
ative control for the polyclonal GPR-30 antibody is shown
in Fig 7L.
Discussion
Impaired cervical ripening is a dominating feature in post
term pregnancy. The trigger initiating the normal cervical
softening including remodelling of the cervical ECM is
unclear. The 100-fold increase of estradiol and progester-
one concentrations, as a result of the placental produc-
tion, in peripheral maternal blood at term pregnancy may
support a role for hormonal regulation. Furthermore, the
significant higher level of fetal fibronectin in cervical
mucus after successful ripening with prostaglandin-E2
supports a possible fetal role in the onset of labour [31].
PCR results for MMP-8, MMP-9 and PAF-R Figure 3
PCR results for MMP-8, MMP-9 and PAF-R. Represent-
ative real-time PCR experiments for expression of MMP-8 
(upper), MMP-9 (middle) and PAF-R (bottom) mRNAs in 
human cervix from the C (n = 11), R (n = 10) and NR (n = 4) 
groups respectively. The values of relative expression of tar-
get genes were normalized against cyclophilin A and dis-
played in arbitrary units. The "box-and-whisker plot" 
represents the median value with 50% of all data falling within 
the box. The whiskers extend to the 5th and 95th percen-
tiles. Boxes with different letter designations are significantly 
different, p < 0.05.
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In previous studies we have been able to show that there
are decreased levels of stromal ERα and ERβ in human cer-
vix immediately post partum as compared to the non-
pregnant state and term, respectively [13]. In the present
study the NR group showed an increased level of ERα
immunostaining compared to the controls whereas ERβ
showed a tendency to increased immunostaining, indicat-
ing a possibility of increased ERα and ERβ levels to be a
sign of decreased spontaneous cervical ripening. How-
ever, there were no differences in Ki-67 immunostaining
between groups, indicating no change in estrogen
response regarding proliferation in the cervix.
In studies on human leukocytes we have found expression
of both ERα and ERβ, the mRNA in several splice variants
and the protein in different sizes both in mononuclear
and polymorphonuclear cells [32]. Leukocytes from rats
treated with selective ER agonists expressed several genes
associated to extracellular matrix remodelling [33]. Fur-
ther studies to evaluate if these genes are involved in the
cervix remodelling in humans are needed.
The recent discovery of GPR30 as an estrogen binding
membrane receptor, made us interested to describe its
expression in the human cervix. GPR30 immunostaining
Representative images of IL-8 immunostaining Figure 4
Representative images of IL-8 immunostaining. Representative images of IL-8 immunostaining of cervical biopsies from 
women non-pregnant (A), term pregnant (B), post partum (C). Second row shows images from women delivered spontane-
ously at term (D), post term women responding to prostaglandin priming (R group) delivering vaginally (E) and post term 
women who did not respond to prostaglandin treatment (NR group) and was delivered by caesarean section (F). A negative 
control where the primary antibody was replaced by an equal amount of mouse IgG, is shown in (G). Abbreviations: V: vessel; 
G: gland and SQ: squamous epithelium. Magnification bars represent 100 μm in all images.Reproductive Biology and Endocrinology 2008, 6:36 http://www.rbej.com/content/6/1/36
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was significantly increased in the NR group as compared
to controls. Thus, this estrogen binding protein behaved
similarly to ERα and ERβ. More studies are needed to elu-
cidate this increase in estrogen binding proteins in the cer-
vix from post term non-responders compared to those
that delivered spontaneously at term. In the hamster ovary
GPR30 was shown to be regulated by the gonadotropins
LH and FSH, whereas estrogen and progesterone had no
effect, when given to hypophysectomized animals [34].
Cervical ripening has been shown to involve an inflam-
matory reaction, including leukocyte influx and activated
fibroblasts [3-6,20,22,35,36]. In the present study it is
notable that IL-8, PAF-R and MMP-9, all predominantly
expressed in leukocytes, are significantly reduced in the
NR group. For IL-8, the level in the NR group is compara-
b l e  t o  t h a t  i n  c e r v i x  f r o m  n o n - p r e g n a n t  w o m e n .  T h e
decrease found could be a secondary effect due to the
impaired accumulation of leukocytes in the non-respond-
ers, since they demonstrated a lower level of leukocytes as
measured by CD45 immunoreactivity, in comparison to
the group responding to prostaglandin treatment.
We have previously shown that CD45 positive cells are
increased in the cervix of women in term pregnancy and
immediately post partum as compared to the non-preg-
nant [3]. No differences were found between term and
post partum, hence the actual delivery does not seem to
change the leukocyte influx. This differs from the results
by Timmons and Mahendroo, who showed that in mice
the leukocyte invasion occurs in labour and not due to
ripening of the cervix. They also conclude that a role for
neutrophils is more probable in postpartum remodelling
of the cervix, rather than in the initiation of cervical ripen-
ing at parturition [37]. Another group stated though that
the above study is the only one showing no increase of
neutrophils prior to parturition in mice, and speculate
that the different way of measuring immune cells (in a
suspension of tissue with a hemacytometer) could be the
reason for the different result [38]. Yellon et al. concluded
that wild-type mice demonstrate an increased presence of
macrophages, as well as reduced collagen structure in the
cervix in late pregnancy, which is consistent with the
hypothesis that recruitment of macrophages is important
for cervical remodelling before term [38].
In the present study the influx of CD45 positive leuko-
cytes is strongest in the R group, thereafter the C group
and significantly lower in the NR group. Thus, if the post-
term women were able to react on prostaglandin treat-
ment the accumulation of leukocytes was restored to, or
even tended to overcome, that of the level in the cervix of
women delivering spontaneously at term. Post term
women could be divided into at least two subgroups,
those with non-ripe cervices that with the correct stimu-
lus, like the prostaglandin gel, could progress into labour
and a vaginal delivery; and those that fail to respond to
prostaglandin stimulation and have to be delivered by
caesarean section.
In term and preterm cervical ripening mRNAs of the three
isomers of NOS, nNOS, eNOS and iNOS have been iden-
tified. An increased expression of nNOS was registered at
preterm cervical ripening [39]. One of the few articles
which present results from studies on cervix in post term
women showed reduced cervical nitric oxide release in
cervical fluid of post term compared to term women [40].
This decrease in NO levels is in agreement with the
decreased level of leukocytes found in our study, since cer-
tain leukocytes are known to express iNOS [41].
Platelet activating factor (PAF) is a pro-inflammatory
mediator, which has been implicated in parturition. Local
application of PAF in rats induced cervical ripening [35],
whereas a PAF-receptor (PAF-R) antagonist prolonged
parturition [42]. The PAF-R has been identified in human
Table 4: Scoring results of IL-8 immunostaining. 
IL-8 Leukocytes
(median and range)
Glandular epithelium
(median and range)
NP (n = 6) resp (n = 4) 0 (0–1) 0 (0–1)
TP (n = 8) resp (n = 5) 0 (0–1) 1 (0–1)
PP (n = 10) resp (n = 10) 2 (1–2) § 2 (1–3) *
C (n = 18) resp (n = 9) 2 (1–3) 2 (1–3)
R (n = 13) resp (n = 2) 2 (1–3)
NR (n = 10) resp (n = 1) 0 (0–3) #
Glandular epithelium (GE) was not present in all samples why the n is less there. In the post term study it was not possible to do statistical 
calculations of IL-8 immunostaining in GE.
§ = significantly different to NP and TP groups.
* = significantly different to the NP group.
# = significantly different from the C and R groups.Reproductive Biology and Endocrinology 2008, 6:36 http://www.rbej.com/content/6/1/36
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cervical fibroblasts in vitro [43]. We have previously
shown presence of the PAF-R protein in the human uter-
ine cervix in vivo [20]. Stromal PAF-R immunostaining
was most pronounced at term, and decreased after partu-
rition. PAF increases the expression of pro-inflammatory
cytokines e.g. IL-8, and this effect can be abolished using
a PAF-R antagonist (WEB2170) [17,43]. In the immortal-
ized sebaceous gland cell line SZ95 PAF-R activation has
been shown to induce expression of cyclooxygenase-2,
prostaglandin-E2 and IL-8 [44]. Thus, the PAF-R has the
potential to induce these factors, all which have been
shown to be involved in the process of cervical ripening
[4,20]. In the present study the PAF-R expression was
lower in the NR group, possibly due to the lower level of
leukocytes present in this group. The amount of PAF-R
might require a certain level to be able to induce cervical
ripening in response to activation. Lack of activation
might then reduce or inhibit the pro-inflammatory mod-
ulators that have been shown to be the response to PAF-R
activation [21]. This is well in agreement with our present
results showing a lower level of IL-8 in the post term
group not responding to prostaglandin priming.
The remodelling of the cervical ECM includes both
increased synthesis as well as degradation of collagen
fibrils and proteoglycans. MMP-2 and MMP-9 expression
in human cervix increase at term pregnancy, suggesting
involvement of these proteases in the reorganization of
ECM during cervical ripening. In the human cervix, MMP-
2 and MMP-9 are produced by different cell types: MMP-
2 was immunolocalized mainly to stromal fibroblasts and
PCR results for ERα, ERβ and GPR30 Figure 5
PCR results for ERα, ERβ and GPR30. Representative 
real-time PCR experiments for expression of ERα (upper), 
ERβ (middle) and GPR30 (bottom) mRNAs in human cervix 
from the C (n = 11), R (n = 10) and NR (n = 4) groups 
respectively. The values of relative expression of target genes 
were normalized against cyclophilin A and displayed in arbi-
trary units. The "box-and-whisker plot" represents the 
median value with 50% of all data falling within the box. The 
whiskers extend to the 5th and 95th percentiles.
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Immunostaining results of ERα, ERβ and GPR30 Figure 6
Immunostaining results of ERα, ERβ and GPR30. ERα 
(top), ERβ (middle) and GPR30 (bottom) immunostaining 
results in stroma, as assessed by manual scoring (top, bot-
tom) and image analysis (middle) in cervical samples from 
controls (C) (n = 18), responders (R) (n = 13) and non-
responders (NR) (n = 9). The "box-and-whisker plot" repre-
sents the median value with 50% of all data falling within the 
box. The whiskers extend to the 5th and 95th percentiles. 
Boxes with different letter designations are significantly dif-
ferent, p < 0.05.
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Representative images of ERα, ERβ, GPR30 and Ki-67 immunostaining Figure 7
Representative images of ERα, ERβ, GPR30 and Ki-67 immunostaining. Representative images of the immunostaining 
results for ERα (A-C), ERβ (D-F), GPR30 (G-I) and Ki-67 (K), and a negative control for monoclonal antibodies (J) where the 
primary antibody (in this example ERα) was replaced by an equal amount of mouse IgG. A negative control for the GPR30 pol-
yclonal antibody, where the primary antibody was replaced by an equal amount of goat IgG, is shown in (L). Abbreviations: V: 
vessel and SQ: squamous epithelium. Magnification bars represent 30 μm in all images.Reproductive Biology and Endocrinology 2008, 6:36 http://www.rbej.com/content/6/1/36
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smooth muscle cells, whereas MMP-9 was observed exclu-
sively in leukocytes [22]. Taken together with our present
results, data indicate the importance of leukocyte derived
MMP-9 for a spontaneous cervical ripening process. Leu-
kocytes are recognized as a main source of the catabolic
enzymes involved in the remodelling of the cervix during
parturition [45]. The present results suggest that the lower
level of leukocytes lead to a less intensive inflammatory
event and therefore impaired or absent cervical ripening.
The decrease in MMP-9 and PAF-R could be secondary to
the lower leukocyte count.
The syndecan family of transmembrane proteoglycans is
the major source of cell surface heparane sulphates (HS)
on all cell types. Recent in vitro and in vivo data suggest the
involvement of syndecans in the modulation of leuko-
cyte-endothelial interactions and extravasation, the for-
mation of chemokine gradients, participation in
chemokine and growth factor signalling, as well as repair
processes [46]. In vitro IL-8 has been shown to shed from
endothelial cells bound to S-1 and HS, and increased
shedding was accompanied by a significant decrease in
the number of neutrophils migrating across the endothe-
lium [47]. Thus, S-1 could be involved in the influx of leu-
kocytes and the cytokine presentation in the tissue. We
found an increased level of S-1 adjacent to glands in the
controls, where we also found strong immunostaining for
IL-8. In two recent articles S-1 expression in human
endometrium during the menstrual cycle has been
described [48,49]. Although the function of S-1 in normal
endometrium is not known, the changes in expression
related to the hormonally regulated menstrual cycle
[48,49] and after estrogen treatment to ovariectomized
rats [26], suggest a possible role of S-1 in hormone regu-
lated tissue remodelling. In addition S-1, as well as Ki-67,
is primarily expressed in cervix epithelium, where also
ERα and ERβ expression is most pronounced [13].
Conclusion
Failed induction of cervical ripening and delivery of post
term pregnant women was associated with decreased
accumulation of leukocytes, possibly resulting in the
lower levels of factors important for remodelling of the
ECM, such as PAF-R and MMPs determined in the present
study. If the decreased leukocyte influx is the primary
cause, or the secondary result of another factor, maternal
and/or fetal, have to be investigated further.
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